|
BIIB's Net Income Growth by Quarter and Year
Biogen Inc 's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BIIB Net Income (in millions $) |
FY 2020 |
FY 2019 |
FY 2018 |
FY 2017 |
| IV Quarter |
December |
357.50
|
1,439.70
|
944.90
|
-166.30
|
| III Quarter |
September |
703.90
|
1,545.90
|
1,442.90
|
1,226.10
|
| II Quarter |
June |
1,606.50
|
1,494.10
|
915.00
|
862.80
|
| I Quarter |
March |
1,392.60
|
1,408.80
|
1,171.20
|
747.50
|
| FY |
|
4,060.50
|
5,888.50
|
4,474.00
|
2,670.10
|
| BIIB Net Income forth quarter 2020 Y/Y Growth Comment |
Biogen Inc reported drop in Net Income in the forth quarter by -75.17% to $ 357.50 millions, from the same quarter in 2019.
The fall in the forth quarter Biogen Inc 's Net Income compares unfavorably to the Company's average Net Income increase of 12.5%.
Among companies who have reported forth quarter results in the Biotechnology & Drugs industry only one Company has achieved higher year on year Net Income results in the forth quarter. While Biogen Inc ' s Net Income meltdown of -75.17% ranks overall at the positon no. 161 in the forth quarter.
|
| BIIB Net Income ( Y/Y Growth %) |
2020
|
2019 |
2018 |
2017 |
| IV Quarter |
December |
-75.17 % |
52.37 % |
- |
- |
| III Quarter |
September |
-54.47 % |
7.14 % |
17.68 % |
19.02 % |
| II Quarter |
June |
7.52 % |
63.29 % |
6.05 % |
-17.7 % |
| I Quarter |
March |
-1.15 % |
20.29 % |
56.68 % |
-22.87 % |
| FY |
|
-31.04 % |
31.62 % |
67.56 % |
-27.75 % |
BIIB Net Income (Quarter on Quarter Growth %) |
2020
|
2019 |
2018 |
2017 |
| IV Quarter |
December |
-49.21 % |
-6.87 % |
-34.51 % |
- |
| III Quarter |
September |
-56.18 % |
3.47 % |
57.69 % |
42.11 % |
| II Quarter |
June |
15.36 % |
6.05 % |
-21.88 % |
15.42 % |
| I Quarter |
March |
-3.27 % |
49.1 % |
- |
15.37 % |
| FY (Year on Year) |
|
-31.04 % |
31.62 % |
67.56 % |
-27.75 % |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 368.67 % |
12.5 % |
-85.39 % |
| (Sep. 30, 2006) |
|
(June 30. 2006) |
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 368.67 % |
12.5 % |
-85.39 % |
| (Sep. 30, 2006) |
|
(June 30. 2006) |
|
| Net Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020 |
Biogen Inc 's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 4345.95 % |
78.66 % |
-56.18 % |
| (Sep. 30, 2004) |
|
|
| BIIB's IV. Quarter Q/Q Net Income Comment |
In the IV. Quarter 2020 Biogen Inc realized fall in Net Income sequentially by -49.21% to $ 357.50 millions, from $ 703.90 millions achived a quarter before.
This is not huge issue, as Biogen Inc 's Net Income generally gravitate to plunge in this quarter Diana Vieira, a business contributor noted.
Within Biotechnology & Drugs industry only one company achieved higher sequential Net Income growth. While Biogen Inc 's Net Income growth quarter on quarter, overall rank is 157. |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 4345.95 % |
78.66 % |
-56.18 % |
| (Sep. 30, 2004) |
|
|
| BIIB's IV. Quarter Q/Q Net Income Comment |
In the IV. Quarter 2020 Biogen Inc realized fall in Net Income from the previous quarter by -49.21% to $ 357.50 millions, from $ 703.90 millions released in the previous quarter.
It's not important issue, as Net Income always gravitate to dip in this quarter Diana Vieira, a business contributor noted.
Within Biotechnology & Drugs industry only one company achieved higher sequential Net Income growth. While Biogen Inc 's Net Income growth quarter on quarter, overall rank is 157. |
|
Biogen Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Dec 31 2020) |
12 Months Ending
(Sep 30 2020) |
12 Months Ending
(Jun 30 2020) |
12 Months Ending
(Mar 31 2020) |
12 Months Ending
(Dec 31 2019) |
| Cumulative Net Income 12 Months Ending |
$ 4,060.50 |
$ 5,142.70 |
$ 5,984.70 |
$ 5,872.30 |
$ 5,888.50 |
| Y / Y Net Income Growth (TTM) |
-31.04 % |
-4.65 % |
13.12 % |
24.63 % |
31.62 % |
| Year on Year Net Income Growth Overall
Ranking |
# 132 |
# 910 |
# 47 |
# 489 |
# 393 |
| Seqeuential Net Income Change (TTM) |
-21.04 % |
-14.07 % |
1.91 % |
-0.28 % |
9.17 % |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# 466 |
# 1615 |
# 796 |
# 859 |
# 167 |
| Cumulative Net Income growth
Comment |
Biogen Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -31.04% year on year, at Dec 31 2020 compare to the -4.65% decrease at Sep 30 2020. If the Biogen Inc 's fiscal year would end at Dec 31 2020, annual Net Income would be $4,061 millions.
Among companies within the Healthcare sector 10 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 132, from total ranking in previous quarter at 910. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
368.67 % |
12.5 % |
-85.39 % |
|
|
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
1560.25 % |
63.77 % |
-75.52 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 9 |
| Sector |
# 46 |
| S&P 500 |
# 466 |
|
| Cumulative Net Income growth
Comment |
Biogen Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -31.04% year on year, at Dec 31 2020 compare to the -4.65% decrease at Sep 30 2020. If the Biogen Inc 's fiscal year would end at Dec 31 2020, annual Net Income would be $4,061 millions.
Among companies within the Healthcare sector 10 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 132, from total ranking in previous quarter at 910. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
368.67 % |
12.5 % |
-85.39 % |
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
1560.25 % |
63.77 % |
-75.52 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 9 |
| Sector |
# 46 |
| S&P 500 |
# 466 |
|
